寡转移性头颈鳞癌:综合综述
本文综述1995至2018年英文文献,探讨寡转移性头颈鳞癌(SCCHN)的管理。现有数据显示寡转移患者预后优于广泛转移者,回顾性证据提示积极治疗原发灶及局部处理转移灶可改善生存。
要点
- 寡转移性SCCHN患者预后可能优于广泛转移者。
- 诊断时寡转移者,积极治疗原发灶及局部处理转移灶与生存改善相关。
- 寡复发患者行转移灶切除或SBRT与更好生存相关。
核心结论
- 寡转移性SCCHN患者若接受积极治疗可能预后更好。
研究设计与样本
- 综述,检索1995至2018年英文Medline文献,关键词为寡转移性SCCHN、转移灶切除、立体定向体部放疗(SBRT)。
主要发现
- 寡转移性SCCHN患者表现与广泛转移者不同,倾向有更好预后。
- 回顾性证据提示诊断时积极治疗原发灶及局部治疗转移灶可改善生存。
- 对寡复发患者,转移灶切除或SBRT与更好生存相关。
临床怎么用
- 对寡转移性SCCHN可考虑积极治疗原发灶及局部处理转移灶。
- 对寡复发患者可考虑转移灶切除或SBRT以改善生存。
局限性
- 关于寡转移性SCCHN管理的数据有限,且无共识指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There are limited data available regarding the management of oligometastatic squamous cell carcinoma of the head and neck (SCCHN) patients, and no consensus guidelines are available. The objective is to review the available literature for the management of oligometastatic SCCHN. Articles were selected from English Medline literature between 1995 and 2018, searched by using the keywords: oligometastatic SCCHN/metastasectomy/stereotactic body radiation treatment (SBRT). With the available data, oligometastatic SCCHN patients appear to behave differently and tend to have a better prognosis than those with widespread metastases. Retrospective evidence suggests that the aggressive treatment of the primary disease and local treatment of the metastatic sites improves survival in oligometastatic SCCHN at diagnosis. The definitive treatment of the distant metastatic sites using metastasectomy or SBRT correlates with better survival in oligorecurrent patients. Oligometastatic SCCHN patients may have a better prognosis if treated aggressively.
引用
- Vengaloor Thomas T, Packianathan S, Bhanat E, et al. Oligometastatic head and neck cancer: Comprehensive review. Head Neck. 2020. PMID: 32220043. doi:10.1002/hed.26144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。